Developed by 149 experts in the field, The International Consensus Classification of Myeloid and Lymphoid Neoplasms provides key information for use at the microscope to assist in arriving at a swift and accurate diagnosis. Drs. Daniel Arber, Michael J. Borowitz, James Cook, Laurence de Leval, John Goodlad, Robert Hasserjian, Rebecca L. King, Hans-Michael Kvasnicka, and Attilio Orazi lead a team of authors who focus on diagnostic criteria and the clinical significance of each disease entity.
- Offers up-to-date information developed through a Clinical Advisory Committee (CAC) process that included the authors and editors of the former 3rd, 4th, and revised 4th edition World Health Organization (WHO) classification of hematopoietic and lymphoid tumors
- Focuses on diagnostic criteria and includes guidelines as to the clinical significance of each disease authored by a clinician expert
- Provides essential information for pathologists and hematopathologists in practice and in training, as well as oncologists and hematologists who want to better understand the many disease categories that they encounter
,
